ARTICLE: Whole Blood Transfusion for Severe Malarial Anemia in a High Plasmodium falciparum Transmission Setting
AUTHORS: Matthew M Ippolito, Jean-Bertin B Kabuya, Manuela Hauser, Luc K Kamavu, Proscovia Miiye Banda, Lisa R Yanek, Rubab Malik, Modest Mulenga, Jeffrey A Bailey, Gershom Chongwe, Thomas A Louis, Theresa A Shapiro, William J Moss; Southern and Central Africa International Centers of Excellence for Malaria Research
JOURNAL: Clin Infect Dis. 2022 Nov 30;75(11):1893-1902. doi: 10.1093/cid/ciac304.
Abstract
Background: Severe malaria resulting from Plasmodium falciparum infection is the leading parasitic cause of death in children worldwide, and severe malarial anemia (SMA) is the most common clinical presentation. The evidence in support of current blood transfusion guidelines for patients with SMA is limited.
Methods: We conducted a retrospective cohort study of 911 hospitalized children with SMA in a holoendemic region of Zambia to examine the association of whole blood transfusion with in-hospital survival. Data were analyzed in adjusted logistic regression models using multiple imputation for missing data.
Results: The median age of patients was 24 months (interquartile range, 16-30) and overall case fatality was 16%. Blood transfusion was associated with 35% reduced odds of death in children with SMA (odds ratio, 0.65; 95% confidence interval, .52-.81; P = .0002) corresponding to a number-needed-to-treat (NNT) of 14 patients. Children with SMA complicated by thrombocytopenia were more likely to benefit from transfusion than those without thrombocytopenia (NNT = 5). Longer storage time of whole blood was negatively associated with survival and with the posttransfusion rise in the platelet count but was not associated with the posttransfusion change in hemoglobin concentration.
Conclusions: Whole blood given to pediatric patients with SMA was associated with improved survival, mainly among those with thrombocytopenia who received whole blood stored for <4 weeks. These findings point to a potential use for incorporating thrombocytopenia into clinical decision making and management of severe malaria, which can be further assessed in prospective studies, and underline the importance of maintaining reliable blood donation networks in areas of high malaria transmission.
For the full article, click here.
For a link to the abstract, click here.
